Nebulized Amikacin Versus Intravenous Amikacin in the Treatment of Nosocomial Pneumonia

NACompletedINTERVENTIONAL

Enrollment

133

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions

Pneumonia

Interventions

DRUG

Nebulized Amikacin

400mg twice daily nebulized amikacin

DRUG

Intravenous Amikacin

20mg/kg once daily intravenous amikacin

All Listed Sponsors

lead

National Heart Institute, Egypt

OTHER_GOV

NCT02728518 - Nebulized Amikacin Versus Intravenous Amikacin in the Treatment of Nosocomial Pneumonia | Biotech Hunter | Biotech Hunter